Trial Profile
Effect of febuxostat in patients with hypertension and hyperuricemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Oct 2015
Price :
$35
*
At a glance
- Drugs Febuxostat (Primary)
- Indications Hypertension; Hyperuricaemia
- Focus Pharmacodynamics
- 19 Oct 2015 Results published in the Clinical Drug Investigation
- 19 Mar 2015 New trial record